Fort Lauderdale, Florida (May 8, 2002) – Switching to XALATAN® (latanoprost ophthalmic solution) once daily from monotherapy with other medications, including prostaglandin derivatives, for open angle ...
Please provide your email address to receive an email when new articles are posted on . Once-daily dosing of NCX 470 demonstrated noninferiority compared with latanoprost in lowering IOP in patients ...
Peapack, New Jersey (May 2, 2002) - Data presented for the first time at the XXIXth International Congress of Ophthalmology in Sydney, Australia, show that long-term (5-year) adjunctive treatment with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback